-+ 0.00%
-+ 0.00%
-+ 0.00%

Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection

PUBT·08/12/2026 09:00:21
Listen to the news
Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection
  • Humanwell unit Yichang Humanwell Pharma won China NMPA clearance to start a clinical trial for sufentanil citrate injection.
  • Study targets a new use in labor analgesia via epidural dosing with bupivacaine, expanding beyond existing anesthesia indications.
  • R&D spending on the program totals about CNY 300,000 to date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humanwell Healthcare (Group) Co. Ltd. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.